Bayers 3.5 Billion Bet on What Others Abandoned At a media event in Spain, Benjamin Maino, Bayers Global Lead for Cell and Gene Therapy Product Supply, disclosed that the company has invested approximately 3.5 billion in the space, including acquisitions of BlueRock Therapeutics and Asklepios Biopharmaceutical
In one such video, a svelte young woman on a couch asks a doctor, "I'm only looking to lose a couple of pounds, maybe use it temporarily." The doctor assures her it's fine for brief use
La tirzepatida se administra mediante inyeccin subcutnea una vez por semana , preferiblemente el mismo da cada semana, sin importar las comidas
By utilizing this multi-receptor agonist, researchers can explore complex pathways in glucose-dependent insulin secretion, energy expenditure, and lipid metabolism
This is not surprising as media coverage, television ads, and success stories have led patients to believe GLP-1s could be a one-stop solution where fad diets and exercise have failed them
As a practicing clinician and active Vineyard member, Erica brings personal experience with weight loss medications, offering a unique blend of empathy and clinical insight